C
VRTX icon

Certuity’s Vertex Pharmaceuticals VRTX Stock Holding History

Certuity’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Buy
7,449
+1,520
+26% +$674K 0.18% 71
2026
Q1 		$2.65M Sell
5,929
-510
-8% -$238K 0.17% 83
2025
Q4 		$2.92M Buy
6,439
+941
+17% +$406K 0.18% 81
2025
Q3 		$2.15M Buy
5,498
+2,189
+66% +$915K 0.15% 95
2025
Q2 		$1.47M Buy
3,309
+139
+4% +$64.1K 0.14% 101
2025
Q1 		$1.54M Sell
3,170
-132
-4% -$61.5K 0.16% 90
2024
Q4 		$1.33M Sell
3,302
-480
-13% -$222K 0.14% 96
2024
Q3 		$1.76M Sell
3,782
-737
-16% -$354K 0.19% 93
2024
Q2 		$2.12M Buy
4,519
+431
+11% +$187K 0.17% 74
2024
Q1 		$1.71M Buy
4,088
+1,508
+58% +$637K 0.15% 80
2023
Q4 		$1.05M Buy
2,580
+433
+20% +$160K 0.11% 105
2023
Q3 		$747K Buy
2,147
+339
+19% +$119K 0.09% 98
2023
Q2 		$636K Buy
1,808
+821
+83% +$277K 0.07% 121
2023
Q1 		$311K Buy
987
+141
+17% +$42.3K 0.05% 155
2022
Q4 		$244K Sell
846
-2,697
-76% -$822K 0.04% 179
2022
Q3 		$1.03M Buy
3,543
+2,754
+349% +$792K 0.24% 50
2022
Q2 		$222K Buy
+789
New +$211K 0.06% 191
2021
Q4 		– Sell
-1,119
Closed -$204K – 404
2021
Q3 		$204K Sell
1,119
-36
-3% -$7.03K 0.04% 364
2021
Q2 		$233K Sell
1,155
-23
-2% -$4.81K 0.05% 287
2021
Q1 		$253K Buy
1,178
+188
+19% +$41.3K 0.07% 239
2020
Q4 		$234K Buy
+990
New +$227K 0.08% 195
2020
Q2 		– Sell
-1,446
Closed -$338K – 221
2020
Q1 		$338K Sell
1,446
-31
-2% -$7.11K 0.19% 89
2019
Q4 		$323K Buy
+1,477
New +$299K 0.15% 112

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Certuity's VRTX Position: Q2 2026 in Review

Certuity increased its Vertex Pharmaceuticals (VRTX) stake by 26% in Q2 2026, buying an estimated $674K and bringing the position to 7,449 shares worth $3.7M. The position accounts for 0.18% of the portfolio, ranked #71.

Certuity first reported a position in VRTX in Q4 2019 and has held it in 23 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Certuity held 7,449 shares of Vertex Pharmaceuticals worth $3.7M as of Q2 2026.
  • Certuity bought 1,520 Vertex Pharmaceuticals shares in Q2 2026, an estimated $674K.
  • Vertex Pharmaceuticals made up 0.18% of Certuity's portfolio in Q2 2026, its #71 holding.
  • Certuity first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 23 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.